DrugPatentWatch Database Preview
Deva Holding As Company Profile
» See Plans and Pricing
What is the competitive landscape for DEVA HOLDING AS, and what generic and branded alternatives to DEVA HOLDING AS drugs are available?
DEVA HOLDING AS has three approved drugs.
Drugs and US Patents for Deva Holding As
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deva Holding As | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 214491-001 | Dec 21, 2020 | AP | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | ESOMEPRAZOLE SODIUM | esomeprazole sodium | INJECTABLE;INTRAVENOUS | 207181-001 | Mar 6, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-001 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-004 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-003 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-006 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-005 | Apr 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.